Hospitals Segment to Dominate Middle East & Africa Embolization Agents Market during 2019–2028

According to a new market research study on “Middle East & Africa Embolization Agents Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Application, and End User,” is expected to reach US$ 194.31 million by 2028 from US$ 124.75 million in 2021. The market is estimated to grow at a CAGR of 6.5% from 2021 to 2028. Rise in the incidence of hypertension, obesity, smoking, and alcoholism is the major factor driving the growth of the Middle East & Africa embolization agents market. However, high cost of embolization agents may hinder the growth of Middle East & Africa embolization agents market. The report provides trends prevailing in the Middle East & Africa embolization agents market along with the drivers and restraints pertaining to the market growth.

The healthcare sector in the UAE has undergone a considerable number of infrastructure and procedural changes to position itself as a leading healthcare provider. These improvements have attracted continuous investments for the improvement of hard and soft infrastructure during the COVID-19 pandemic. Due to COVID-19, a substantial number of planned elective surgery operations were cancelled or postponed in this region. Since the beginning of 2020, the COVID-19 pandemic has caused enormous health and socioeconomic impacts, which are likely to continue in 2021 as well. The pandemic has caused disruptions in health services and has impacted the ability of countries to address and respond to noncommunicable diseases (NCDs). Moreover, economic uncertainties and ongoing conflicts are worsening the conditions in the Middle East and Africa. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures; moreover, Iran was in a deep economic recession due to the US sanctions.

The embolization agents market is segmented into product, application, end user, and country. Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, others. The beads/particles segment held the largest share of the market in 2020. Based on coils the market is divided into detachable coils and pushable coils. The pushable coils segment held the largest share of the market in 2020. Based on beads/particles the market is divided into spherical and non-spherical. The pushable non-spherical segment held the largest share of the market in 2020. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2020, the oncology segment is likely to hold the largest share of the market. The embolization agents market by end user, is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held the largest share of the market in 2020. Based on country the market is divided into Saudi Arabia, South Africa, UAE, and rest of Middle East & Africa. In 2020, Saudi Arabia is likely to hold the largest share of the market.

Abbott; Boston Scientific Corporation; Cook Medical LLC; DePuy Synthes; KANEKA CORPORATION; Medtronic; Merit Medical Systems Inc; Stryker Corporation; and Terumo Corporation are among the leading companies in the Middle East & Africa embolization agents market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Stryker got their Neuroform Atlas Stent System has been authorized by the US Food and Drug Administration (FDA) for an expanded indication, making it the first and only adjunctive stent approved for use in the posterior (rear of the brain) circulation. Long-term treatment is now possible due to the approval of the Neuroform Atlas adjunctive stent for the posterior circulation. This Atlas stent system is used in conjunction with embolic detachable coils.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com